Effect of Sage Essential Oil Inhalation Aromatherapy on Premenstrual Symptoms and Quality of Life
NCT ID: NCT05823207
Last Updated: 2023-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
86 participants
INTERVENTIONAL
2023-05-31
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Aromatherapy Application With Bergamot and Grapefruit Essential Oils on PMS
NCT06289764
The Effect of Aromatherapy in Women With Primiparous Cesarean Section
NCT06119282
The Effect of Aromatherapy Applied After Cesarean Section on Pain Intensity and Comfort Level
NCT06008964
The Effect Of Reiki And Massage With Sage Oil On Primary Dysmenorrhea
NCT05129852
The Effect of Foot Bath on PMS, Sleep and Quality of Life Among University Students With PMS
NCT05264519
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
From this point of view, studies have shown that aromatherapy has an effect on reducing premenstrual symptoms and increasing quality of life. This research, It is thought that it will both create a resource for nurses and contribute to the formation of the necessary evidence for the application of sage oil in aromatherapy in people with PMS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sage essential oil
Sage essential oil is applied twice a day for a total of 6 drops for 5 days in each cycle.
sage essential oil
It will be applied 2 times a day, at the same times, at a distance of 30 cm from the nose for 5 minutes with normal breathing and 3 drops of essential oil by placing a tampon. The PMS scale and the quality of life scale are administered to the participants at the end of the 1st, 2nd and 3rd cycles of the menstrual cycle.
control group
No application was made to this group. Personal information form and PMS scale and quality of life scale will be applied to this group at the end of each cycle.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sage essential oil
It will be applied 2 times a day, at the same times, at a distance of 30 cm from the nose for 5 minutes with normal breathing and 3 drops of essential oil by placing a tampon. The PMS scale and the quality of life scale are administered to the participants at the end of the 1st, 2nd and 3rd cycles of the menstrual cycle.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experiencing at least five PMS symptoms each month,
* Not having sexual intercourse
* Regular menstruation, (regular menstruation (between 21-35 days) )
* Absence of any chronic disease,
* Not using any method to deal with PMS
* No known allergic reaction to the essential oil to be used,
* Those who are not bothered by the smell of the essential oil to be used and accept the use of sage essential oil
* Not taking Hormone Replacement Therapy
* Women who agreed to participate in the study were included in the study group.
Exclusion Criteria
* Allergy,
* Individuals with inconvenient conditions (nausea, dizziness, febrile diseases, high fever, skin or joint inflammation, unknown itching and redness, unknown edema, open wound, cancer, recent operation, intra-abdominal surgery, cyst, appendicitis) ),
* Irregular menstruation,
* Not having regular periods in the last three months,
* Having a psychiatric diagnosis,
* Having any gynecological disease (abnormal uterine bleeding, myoma, ovarian cyst, etc.)
* Using contraceptive drugs,
* Those with olfactory problems (anosmia)
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cansu Mine Aydin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cansu Mine Aydin
research assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
özlem karabulutlu, assoc.dr
Role: PRINCIPAL_INVESTIGATOR
kafkas univesity
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KAFKAS-SAG-CMAYDIN-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.